Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P51532 (
transcriptional activator
)
6,546
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Jade-1
was identified as a protein partner of the von Hippel-Lindau tumor suppressor pVHL. The interaction of
Jade-1
and pVHL correlates with renal cancer risk. We have investigated the molecular function of
Jade-1
.
Jade-1
has two zinc finger motifs called plant homeodomains (PHD). A line of evidence suggests that the PHD finger functions in chromatin remodeling and protein-protein interactions. We determined the cellular localization of
Jade-1
and examined whether
Jade-1
might have transcriptional and histone acetyltransferase (HAT) functions. Biochemical cell fractionation studies as well as confocal images of cells immunostained with a specific
Jade-1
antibody revealed that endogenous
Jade-1
is localized predominantly in the cell nucleus. Tethering of Gal4-
Jade-1
fusion protein to Gal4-responsive promoters in co-transfection experiments activated transcription 5-6-fold, indicating that
Jade-1
is a possible
transcriptional activator
. It was remarkable that overexpression of
Jade-1
in cultured cells specifically increased levels of endogenous acetylated histone H4, but not histone H3, strongly suggesting that
Jade-1
associates with HAT activity specific for histone H4. Deletion of the two PHD fingers completely abolished
Jade-1
transcriptional and HAT activities, indicating that these domains are indispensable for
Jade-1
nuclear functions. In addition, we demonstrated that TIP60, a known HAT with histone H4/H2A specificity, physically associates with
Jade-1
and is able to augment
Jade-1
HAT function in live cells, strongly suggesting that TIP60 might mediate
Jade-1
HAT activity. Thus,
Jade-1
is a novel candidate transcriptional co-activator associated with HAT activity and may play a key role in the pathogenesis of renal cancer and von Hippel-Lindau disease.
...
PMID:von Hippel-Lindau partner Jade-1 is a transcriptional co-activator associated with histone acetyltransferase activity. 1550 58